Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Non Small Cell Lung Cancer × Platinum Compounds × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Esophageal Neoplasms 2 Sjogren's Syndrome 1 Scleroderma, Systemic 1 Psoriasis 1 NSCLC 1 Multiple Sclerosis 1 Melanoma 1 Lupus Erythematosus, Systemic 1 Lung Neoplasms 1 Inflammatory Bowel Diseases 1 Hematologic Neoplasms 1 Dermatomyositis 1 Crohn Disease 1 Colitis, Ulcerative 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Arthritis, Psoriatic 1

Interventions

pembrolizumab 1 osimertinib 1 durvalumab 1 AZD 6244 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡